#fragmentomics 搜尋結果
🧬 We are honoured to have Dr. Jinglan Zhang joining us at #CNAPS2025! Dr. Zhang is a Qiushi Distinguished Professor at Zhejiang University. His work has significantly advanced the understanding of human genetic conditions and their prenatal diagnosis. #gene #fragmentomics
6/15 A tumor fraction ROC was then generated and, using an optimized cutpoint, distinguished MPNST from PN subjects on pre-treatment (Sp 91%, Sn 75%) and serial (Sp 91%, Sn 83%) samples. #Fragmentomics of tumor fraction high and low samples mirror that of MPNST and PN.
Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics 🔦 buff.ly/dsaLPGJ #Fragmentomics #ctDNA #DNAmet #DNAmethylation
DNA size profile and fragment-end composition #fragmentomics roughly equivalent to #cfDNA size profile with added HMW for sEV fractions. In silica selection of HMW does not reveal enrichment in tumor signal in these HMW.
cfDNA fragmentomics is the category of histology formed by integrating the fragment characteristics of cfDNA. The #fragmentomics of #cfDNA holds promise for the noninvasive detection of tissue-specific diseases. 📚Cell-Free DNA Fragmentomics: The Novel Promising Biomarker
Ymke van der Pol, PhD student in our lab, presenting her work on #fragmentomics and #cfDNA at the #CNAPS2022 in San Francisco. See the corresponding paper here: doi.org/10.1093/clinch…
Excited for @alexandercpan’s #AACR2023 poster using #cfdna #fragmentomics to distinguish benign, pre-malignant and malignant tumors in #NF1. Visit the @NCI_CCR_PedOnc @WUSTLmed collaborative product Section 41 poster 7! Contrib: @aadel_chaudhuri @jack_shern @AngelaHirbe
Join us as Dr. Umberto Malapelle explores the latest in tumor profiling, including #fragmentomics and methylation signatures in cfDNA. Learn more at #PrecisionInPractice on September 27th and 28th. Contact: [email protected]
We kept busy this summer investing in 3 more startups! First up was RealSeq Biosciences that closed an oversubscribed $1.5 Mill round. Using next-gen #RNA #fragmentomics tech, RealSeq helps capture hard-to-detect circulating nucleic acid biomarkers of disease activity.
Future of liquid biopsies is multi-omics - @pashtoonkasi @Annals_Oncology #Cancer #Epigenomics #Fragmentomics #LiquidBiopsies #OncoDaily #Oncology #Proteomics oncodaily.com/14062.html
✨ We are thrilled to welcome Prof. Claus Lindbjerg Andersen at #CNAPS2025! Prof. Andersen’s work focuses on the use of ctDNA as a biomarker for early cancer detection, prognosis, and monitoring, particularly in colorectal cancer. #CNAPS #fragmentomics #liquidbiopsy
How will precision medicine change #Healthcare? Learn the full story from ClaretBio methods #fragmentomics #PMWC20 @PMWCintl
Can #fragmentomics become a new monitoring #biomarker in metastatic breast cancer? 🔬 👉 Here we explore a mutation-agnostic, cost-effective approach tested in the MAGNETIC.1 trial—a longitudinal study of first-line HR+/HER2- MBC. doi.org/10.1016/j.tran…
🚀 Just dropped our take on cancer #epigenomics in liquid biopsy 📰How #methylomics and #fragmentomics are rocking the liquid world🎸💡depicting here the liquidomics journey into Dante's Paradise☄️🌬️ Thanks @UmbertoMalapel1 for your constant vision 👇🏻futuremedicine.com/doi/10.2217/ep…
Join us next week Sept. 17th 📅 for our live webinar💻! We will present an overview of our SRSLY technology (including UMI addition) and its applications for #cfDNA #fragmentomics #rnaseq & #SARSCoV2 enrichment 🧬🧪Registration is free! Find it here: claretbio.com/events/2020/8/…
#fragmentomics ? What a cool name! 😁😎
Last days to apply for a postdoctoral position in my lab in Amsterdam to identify new tumor-derived and #fragmentomics signatures using #cfDNA, #liquidbiopsy and genome-wide sequencing. werkenbijvumc.nl/vacatures/post…
Our @FirstLookLung test evaluates DNA fragments in blood, aiding #earlydetection. The #DELFI team is proud of this innovation to help detect lung cancer early, when it's easier to treat. #fragmentomics #knowledgeispower
We have 2 positions available in my team at the CRUK Cancer Biomarker Centre with a focus on technology development and implementation for #fragmentomics, #cfDNA and #cfRNA.
New vacancy! We are #recruiting for a Senior Scientific Officer - Liquid Biopsy Biomarker Research for Cancer Detection to join our CRUK Cancer Biomarker Centre @cruk_cbc! Interested? Click the link below to apply before the deadline of 14/09/2023!⬇️ cruk.manchester.ac.uk/recruitment/ca…
Our paper in Cancer Discovery (@CD_AACR): A blood sample 🧪 can track #immunotherapy response & predict outcomes across cancer types using #ctDNA methylomes and #fragmentomics. No tumor tissue needed! aacrjournals.org/cancerdiscover… @PughLab @lillian_siu @UHN @pmcancercentre @UofTDRO
🧬 We are honoured to have Dr. Jinglan Zhang joining us at #CNAPS2025! Dr. Zhang is a Qiushi Distinguished Professor at Zhejiang University. His work has significantly advanced the understanding of human genetic conditions and their prenatal diagnosis. #gene #fragmentomics
Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics 🔦 buff.ly/dsaLPGJ #Fragmentomics #ctDNA #DNAmet #DNAmethylation
Join us as Dr. Umberto Malapelle explores the latest in tumor profiling, including #fragmentomics and methylation signatures in cfDNA. Learn more at #PrecisionInPractice on September 27th and 28th. Contact: [email protected]
✨ We are thrilled to welcome Prof. Claus Lindbjerg Andersen at #CNAPS2025! Prof. Andersen’s work focuses on the use of ctDNA as a biomarker for early cancer detection, prognosis, and monitoring, particularly in colorectal cancer. #CNAPS #fragmentomics #liquidbiopsy
Can #fragmentomics become a new monitoring #biomarker in metastatic breast cancer? 🔬 👉 Here we explore a mutation-agnostic, cost-effective approach tested in the MAGNETIC.1 trial—a longitudinal study of first-line HR+/HER2- MBC. doi.org/10.1016/j.tran…
DELFI Founder Dr. Victor Velculescu will be honored with the Pioneer Award at #PMWC25! Listen to his keynote, “Early Detection of Cancer Using Cell-free DNA Fragmentomes.” Feb 6, 9 am PT | Silicon Valley bit.ly/40xzBOu #CancerResearch #Fragmentomics
#DELFI is thrilled to be featured in this recent @medcitynews article. Jason Helgerson describes how the #fragmentomics technology in our @FirstLookLung test may reduce the socioeconomic and geographic barriers to #lungcancerscreening. Read it here: bit.ly/3ClRQhj…
medcitynews.com
Earlier Detection and Treatment are Essential for Meeting VBC Goals - MedCity News
While VBC opens the door to new care models, they alone cannot solve another key driver of healthcare costs: many people are diagnosed late in their disease progression when care costs are higher.
MicroRNA: A New Era in Biomarker Discovery with Tim Williams and Paola Ulivi mendelspod.com/p/microrna-a-n… @Cambridge_Uni @IRSTDinoAmadori #microRNA #biomarkerdevelopment #fragmentomics
DNA size profile and fragment-end composition #fragmentomics roughly equivalent to #cfDNA size profile with added HMW for sEV fractions. In silica selection of HMW does not reveal enrichment in tumor signal in these HMW.
Susan Tousi, CEO of Ilumina Ventures portfolio company @DELFIDiagnostic recently spoke with @Nasdaq to discuss #fragmentomics and its application in DELFI's blood-based FirstLook Test for enhancing #LungCancer screening. See the full interview here: nasdaq.com/videos/delfi-d…
And check out Twitterless Jeff Szymanski’s poster on our collaborative #NF1 #cfDNA #fragmentomics! @AngelaHirbe @jack_shern @alexandercpan @aadel_chaudhuri
Our @FirstLookLung test evaluates DNA fragments in blood, aiding #earlydetection. The #DELFI team is proud of this innovation to help detect lung cancer early, when it's easier to treat. #fragmentomics #knowledgeispower
#AACR24 visit poster at session 37, board 5 for the integration of multi omics in #ctdna release mechanisms and #fragmentomics in longitudinal monitoring
#Fragmentomics #cfDNA #SRSLY #publications #OrganoidResearch #GenomicProfiling #CancerDetection #InVitroModels #ExtrachromosomalDNA #Genomics
The study successfully analyzed fragment size and end motifs, explored DNA binding proteins and footprints, and detected circular DNA across organoid sample libraries. #Fragmentomics #cfDNA #SRSLY #publications #OrganoidResearch #GenomicProfiling #CancerDetection
Our paper in Cancer Discovery (@CD_AACR): A blood sample 🧪 can track #immunotherapy response & predict outcomes across cancer types using #ctDNA methylomes and #fragmentomics. No tumor tissue needed! aacrjournals.org/cancerdiscover… @PughLab @lillian_siu @UHN @pmcancercentre @UofTDRO
🧬 We are honoured to have Dr. Jinglan Zhang joining us at #CNAPS2025! Dr. Zhang is a Qiushi Distinguished Professor at Zhejiang University. His work has significantly advanced the understanding of human genetic conditions and their prenatal diagnosis. #gene #fragmentomics
Tumor-agnostic detection of circulating tumor DNA in patients with advanced pancreatic cancer using targeted DNA methylation sequencing and cell-free DNA fragmentomics 🔦 buff.ly/dsaLPGJ #Fragmentomics #ctDNA #DNAmet #DNAmethylation
Future of liquid biopsies is multi-omics - @pashtoonkasi @Annals_Oncology #Cancer #Epigenomics #Fragmentomics #LiquidBiopsies #OncoDaily #Oncology #Proteomics oncodaily.com/14062.html
Ymke van der Pol, PhD student in our lab, presenting her work on #fragmentomics and #cfDNA at the #CNAPS2022 in San Francisco. See the corresponding paper here: doi.org/10.1093/clinch…
🚀 Just dropped our take on cancer #epigenomics in liquid biopsy 📰How #methylomics and #fragmentomics are rocking the liquid world🎸💡depicting here the liquidomics journey into Dante's Paradise☄️🌬️ Thanks @UmbertoMalapel1 for your constant vision 👇🏻futuremedicine.com/doi/10.2217/ep…
Excited for @alexandercpan’s #AACR2023 poster using #cfdna #fragmentomics to distinguish benign, pre-malignant and malignant tumors in #NF1. Visit the @NCI_CCR_PedOnc @WUSTLmed collaborative product Section 41 poster 7! Contrib: @aadel_chaudhuri @jack_shern @AngelaHirbe
6/15 A tumor fraction ROC was then generated and, using an optimized cutpoint, distinguished MPNST from PN subjects on pre-treatment (Sp 91%, Sn 75%) and serial (Sp 91%, Sn 83%) samples. #Fragmentomics of tumor fraction high and low samples mirror that of MPNST and PN.
DNA size profile and fragment-end composition #fragmentomics roughly equivalent to #cfDNA size profile with added HMW for sEV fractions. In silica selection of HMW does not reveal enrichment in tumor signal in these HMW.
We kept busy this summer investing in 3 more startups! First up was RealSeq Biosciences that closed an oversubscribed $1.5 Mill round. Using next-gen #RNA #fragmentomics tech, RealSeq helps capture hard-to-detect circulating nucleic acid biomarkers of disease activity.
✨ We are thrilled to welcome Prof. Claus Lindbjerg Andersen at #CNAPS2025! Prof. Andersen’s work focuses on the use of ctDNA as a biomarker for early cancer detection, prognosis, and monitoring, particularly in colorectal cancer. #CNAPS #fragmentomics #liquidbiopsy
How will precision medicine change #Healthcare? Learn the full story from ClaretBio methods #fragmentomics #PMWC20 @PMWCintl
Our @FirstLookLung test evaluates DNA fragments in blood, aiding #earlydetection. The #DELFI team is proud of this innovation to help detect lung cancer early, when it's easier to treat. #fragmentomics #knowledgeispower
Join us next week Sept. 17th 📅 for our live webinar💻! We will present an overview of our SRSLY technology (including UMI addition) and its applications for #cfDNA #fragmentomics #rnaseq & #SARSCoV2 enrichment 🧬🧪Registration is free! Find it here: claretbio.com/events/2020/8/…
Susan Tousi, CEO of Ilumina Ventures portfolio company @DELFIDiagnostic recently spoke with @Nasdaq to discuss #fragmentomics and its application in DELFI's blood-based FirstLook Test for enhancing #LungCancer screening. See the full interview here: nasdaq.com/videos/delfi-d…
DELFI Founder Dr. Victor Velculescu will be honored with the Pioneer Award at #PMWC25! Listen to his keynote, “Early Detection of Cancer Using Cell-free DNA Fragmentomes.” Feb 6, 9 am PT | Silicon Valley bit.ly/40xzBOu #CancerResearch #Fragmentomics
Something went wrong.
Something went wrong.
United States Trends
- 1. Caleb Love 2,854 posts
- 2. Mamdani 470K posts
- 3. Sengun 8,683 posts
- 4. Marjorie Taylor Greene 71.3K posts
- 5. Reed Sheppard 3,868 posts
- 6. Suns 20.7K posts
- 7. Collin Gillespie 4,028 posts
- 8. Morgan Geekie N/A
- 9. Norvell 3,553 posts
- 10. Lando 48.5K posts
- 11. #SmackDown 47.4K posts
- 12. UNLV 2,245 posts
- 13. Blazers 4,063 posts
- 14. Kerr 5,164 posts
- 15. The View 97.5K posts
- 16. Florida State 10.9K posts
- 17. #DBLF2025 12.8K posts
- 18. Wolves 16.4K posts
- 19. Rockets 16.7K posts
- 20. #LasVegasGP 73.7K posts